53 results
424B3
BXRXQ
Baudax Bio, Inc.
22 Nov 23
Prospectus supplement
4:58pm
A with inhibitors was cleared by the FDA.
Tregs are designed to recognize and target certain cells through the engagement of target-specific receptors
8-K
BXRXQ
Baudax Bio, Inc.
25 Oct 23
Changes in Registrant's Certifying Accountant
7:57am
October 19, 2023, is filed as Exhibit 16.1 to this Current Report on Form 8-K.
Engagement of Former Independent Registered Public Accounting Firm …
On October 19, 2023, in connection with the Company’s dismissal of EisnerAmper, the Board approved the engagement of KPMG LLP (“KPMG”) as its new
PRER14A
ta8tu6gi
25 Aug 23
Preliminary revised proxy
4:01pm
424B5
d8gffb0fap 9elf2v0
18 Aug 23
Prospectus supplement for primary offering
4:40pm
DEFA14A
EX-99.1
ouqr aaeeyp7
9 Aug 23
Additional proxy soliciting materials
5:28pm
8-K/A
EX-99.1
xdjlzraiduf04nze4
9 Aug 23
Other Events
5:27pm
DEFA14A
h5aczos51pfmhugupdms
5 Jul 23
Additional proxy soliciting materials
5:28pm
8-K
EX-10.1
2e316t
5 Jul 23
Entry into a Material Definitive Agreement
5:26pm
424B3
iaeb93mihf lx0m
28 Apr 23
Prospectus supplement
4:02pm